Magnetic Resonance Imaging (MRI) Guided And Focused Ultrasound Devices Market Report 2026

Magnetic Resonance Imaging (MRI) Guided And Focused Ultrasound Devices Market Overview

• Magnetic Resonance Imaging (MRI) Guided And Focused Ultrasound Devices market size has reached to $3.14 billion in 2025 • Expected to grow to $5.43 billion in 2030 at a compound annual growth rate (CAGR) of 11.5% • Growth Driver: Rising Incidence Of Neurological Disorders Fueling The Growth Of The Market Due To Aging Population And Increasing Diagnostic Needs • Market Trend: Next-Generation System Enhances Precision And Efficiency • North America was the largest region in 2025.

What Is Covered Under Magnetic Resonance Imaging (MRI) Guided And Focused Ultrasound Devices Market?

Magnetic resonance imaging (MRI)-guided focused ultrasound devices are advanced medical technologies that combine MRI imaging with high-intensity focused ultrasound to target specific tissues precisely. It helps to non-invasively treat conditions by delivering focused energy while continuously monitoring the treatment area with magnetic resonance imaging (MRI) for accuracy and safety. These devices minimize damage to surrounding healthy tissues and reduce the need for surgical intervention. The main types of magnetic resonance imaging (MRI)-guided focused ultrasound devices are magnetic resonance imaging (MRI)-guided and focused ultrasound. Magnetic resonance imaging (MRI)-guided refers to the use of MRI technology to precisely visualize and monitor internal tissues and organs in real time, allowing clinicians to guide, plan, and assess medical procedures or therapies with high accuracy and without ionizing radiation. Based on treatment types, these devices are classified as thermal ablation, non-thermal ablation, and drug delivery systems, and utilize technologies such as magnetic resonance imaging (MRI)-guided ultrasound, focused ultrasound therapy, ultrasound imaging systems, and combination systems. These devices find applications in oncology, neurology, cardiology, urology, and others, serving end users such as hospitals, clinics, ambulatory surgical centers, and research and academic institutes.

What Is The Magnetic Resonance Imaging (MRI) Guided And Focused Ultrasound Devices Market Growth Forecast?

The magnetic resonance imaging (mri) guided and focused ultrasound devices market size is expected to see rapid growth in the next few years. It will grow to $5.43 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to expansion of non-invasive neurosurgical treatments, integration of ai-based therapy control, growing demand for outpatient treatment solutions, rising investments in precision medicine, broader regulatory approvals for focused ultrasound. Major trends in the forecast period include MRI-guided non-invasive therapy, ai-assisted treatment planning, real-time image-guided precision ablation, integrated imaging and therapy platforms, data-driven treatment monitoring.

Global Magnetic Resonance Imaging (MRI) Guided And Focused Ultrasound Devices Market Segmentation

1) By Type: Magnetic Resonance Imaging (MRI) Guided, Focused Ultrasound 2) By Treatment Type: Thermal Ablation, Non-Thermal Ablation, Drug Delivery Systems 3) By Technology: Magnetic Resonance Imaging (MRI) Guided Ultrasound, Focused Ultrasound Therapy, Combination Systems 4) By Application: Oncology, Neurology, Cardiology, Urology, Other Applications 5) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Research And Academic Institutes Subsegments: 1) By Magnetic Resonance Imaging (MRI) Guided: High-Intensity Focused Ultrasound (HIFU), Low-Intensity Focused Ultrasound (LIFU) 2) By Focused Ultrasound: Therapeutic Focused Ultrasound, Diagnostic Focused Ultrasound, Neurological Applications, Urological Applications, Oncological Applications

What Is The Driver Of The Magnetic Resonance Imaging (MRI) Guided And Focused Ultrasound Devices Market?

The rising incidence of neurological disorders is expected to propel the growth of the magnetic resonance imaging (MRI)-guided focused ultrasound devices market going forward. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, leading to a range of symptoms, including cognitive, motor, and sensory impairments. The increasing prevalence of neurological disorders is linked to the aging global population, as aging gradually impairs neuronal function, reduces brain plasticity, and elevates oxidative stress, contributing to the development and progression of these conditions. Magnetic resonance imaging (MRI)-guided focused ultrasound devices aid in neurological disorder diagnosis by providing real-time imaging combined with non-invasive treatment capabilities, making them ideal for precise targeting of affected brain regions. They improve diagnostic accuracy and treatment planning by offering detailed visualization and focused therapy, enhancing patient outcomes and clinical efficiency. For instance, in July 2024, according to the National Health Service, a UK-based government agency, there were 487,432 patients diagnosed with dementia (a progressive brain disorder affecting memory, thinking, and daily activities) by June 30, 2024, an increase of 3,155 cases compared to May 31, 2024. Therefore, the rising incidence of neurological disorders is driving the growth of the magnetic resonance imaging (MRI)-guided focused ultrasound devices market.

Key Players In The Global Magnetic Resonance Imaging (MRI) Guided And Focused Ultrasound Devices Market

Major companies operating in the magnetic resonance imaging (mri) guided and focused ultrasound devices market are InSightec Ltd, EDAP TMS SA, Image Guided Therapy SA, Profound Medical Inc, Cardiawave, Focal One, FUS Instruments Inc, Theraclion SA, Siemens Healthineers, GE Healthcare, Koninklijke Philips NV, EpiSonica Corp, Kona Medical Inc, Mirabilis Medical Inc, Chongqing Haifu Technology Co Ltd, Shanghai A&S Co Ltd, Shenzhen PRO‑HIFU Medical Tech Co Ltd, Changjiangyuan Technology Development Co Ltd, Wuxi Haiying Medical Co Ltd, Elekta AB, CarThera, Monteris Medical, Eye Tech Care, HistoSonics Inc, NaviFUS Corp, NeuroBlate (Monteris Medical)†, HIFU Devices Inc.

Global Magnetic Resonance Imaging (MRI) Guided And Focused Ultrasound Devices Market Trends and Insights

Major companies operating in the magnetic resonance imaging (MRI)-guided focused ultrasound devices market are focusing on developing advanced products, such as next-generation MR-guided focused ultrasound systems, to improve precision, expand applications, and enhance patient outcomes. Next-generation MR-guided focused ultrasound systems refer to advanced medical platforms that combine real-time MRI imaging with high-intensity focused ultrasound, offering improved precision, automation, usability, and expanded clinical applications compared to earlier systems. For instance, in January 2024, Insightec Ltd., an Israel-based medical technology company, launched the Exablate Prime system, a next-generation MR-guided focused ultrasound (MRgFUS) platform. It features intelligently designed algorithms, automated task-based workflows, and seamless integration with hospital systems like PACS, enabling remote physician planning and technical support. Its enhanced computing architecture supports up to 150 reports, and the system includes a high-resolution monitor for optimized imaging and a cross transducer designed for optimal performance during MR-guided procedures. The Exablate Prime system builds on a decade of research and user feedback, aiming to provide unmatched precision in neurosurgical applications, such as treating essential tremor and Parkinson’s disease, while reducing procedure times and improving operational efficiency.

What Are Latest Mergers And Acquisitions In The Magnetic Resonance Imaging (MRI) Guided And Focused Ultrasound Devices Market?

In February 2025, Grovecourt Capital Partners LLC, a US-based investment company, acquired IMRIS Imaging Inc. for an undisclosed amount. With this acquisition, Grovecourt Capital Partners aims to expand its portfolio in the medical imaging and advanced surgical technologies sector, strengthening its presence in high-growth healthcare markets and gaining access to IMRIS’s expertise in MRI-guided and hybrid operating room solutions. IMRIS Imaging Inc. is a US-based medical equipment manufacturer specializing in magnetic resonance imaging (MRI)-guided and focused ultrasound devices.

Regional Outlook

North America was the largest region in the magnetic resonance imaging (MRI)-guided focused ultrasound devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Magnetic Resonance Imaging (MRI) Guided And Focused Ultrasound Devices Market?

The magnetic resonance imaging (MRI)-guided focused ultrasound devices market consists of revenues earned by entities by providing services such as image-guided therapy procedures, non-invasive treatment planning, system maintenance, and clinical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The magnetic resonance imaging (MRI)-guided focused ultrasound devices market also includes sales of transducers, treatment planning software, patient positioning systems, and related accessories and consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.